Innovating Pharmaceutical Therapies
Pioneering the world’s first prescription CBD for social anxiety disorder.
Extraordinary Leadership. Unparalleled Experience.
EmpowerPharm is conducting clinical studies using cannabidiol (CBD) for prescription medicines to treat social anxiety disorder.
EmpowerPharm Inc. is a Canadian owned pharmaceutical company dedicated to creating a company driven for social impact. Leveraging our diverse expertise as industry leaders, we specialize in the research, development, manufacturing, and commercialization of medicines with novel formulations in our state-of-the-art GMP pharmaceutical facility located in Burlington, Canada.
Our Mission: We are empowered to develop and commercialize products through improved drug delivery technology that will improve patient therapeutic outcomes and quality of life
CurrentNews
EmpowerPharm, independent research report by Crystal Research Associates
EmpowerPharm Inc. (“EmpowerPharm” or “the Company”) is a Canadian pharmaceutical company dedicated to developing pharmaceutical grade cannabidiol (CBD)† therapies in ...
Read More →
Revolutionizing Adult Epilepsy Treatment: Our Expanded Research Using Super SNEDDS Technology
In the evolving landscape of neurological disorders, epilepsy stands out as a complex challenge that affects millions of adults worldwide. The quest for more effective ...
Read More →
EmpowerPharm Inc. is delighted to announce the outcome of their Phase 2 clinical trial assessing Cannabidiol (CBD) drug product for Social Anxiety Disorder (SAD)
EmpowerPharm Inc. https://empowerpharm.ca/ is delighted to announce the outcome of their Phase 2 clinical trial assessing the dose finding, efficacy, safety, and tolerability of Cannabidiol ...
Read More →
EmpowerPharm, independent research report by Crystal Research Associates
EmpowerPharm Inc. (“EmpowerPharm” or “the Company”) is a Canadian pharmaceutical company dedicated to developing pharmaceutical grade cannabidiol (CBD)† therapies in ...
Read More →
Revolutionizing Adult Epilepsy Treatment: Our Expanded Research Using Super SNEDDS Technology
In the evolving landscape of neurological disorders, epilepsy stands out as a complex challenge that affects millions of adults worldwide. The quest for more effective ...
Read More →